FHLT — Future Health ESG Cashflow Statement
0.000.00%
- $65.06m
- $64.94m
Annual cashflow statement for Future Health ESG, fiscal year end - December 31st, millions except per share.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | — | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | |
Standards: | — | USG | USG | USG |
Status: | fx Preliminary | Final | Final | Final |
Net Income/Starting Line | — | -0.181 | 0.06 | -0.048 |
Deferred Taxes | ||||
Non-Cash Items | — | -0.004 | -2.6 | -0.771 |
Unusual Items | ||||
Changes in Working Capital | — | -0.059 | 1.08 | 0.206 |
Change in Prepaid Expenses | ||||
Change in Payable / Accrued Expenses | ||||
Cash from Operating Activities | — | -0.244 | -1.26 | -0.718 |
Other Investing Cash Flow Items | — | -201 | 187 | 0 |
Sale/Maturity of Investment | ||||
Purchase of Investments | ||||
Cash from Investing Activities | — | -201 | 187 | 0 |
Financing Cash Flow Items | — | 0.25 | 0 | — |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | — | 203 | -187 | 0 |
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | — | 1.45 | -0.609 | -0.718 |